Becker's Healthcare February 1, 2023
Paige Twenter and Giles Bruce

Amazon has experimented with different projects in healthcare the past few years, but its current focus seems to be at the pharmacy counter — the digital one, at least.

Its latest declaration to the industry came last week when it debuted RxPass, a $5-a-month generic drug plan for Prime members.

With the new service, “Amazon surely is disrupting the retail pharmacy business,” Kiran Avancha, PhD, chief innovation officer of Scottsdale, Ariz.-based HonorHealth, told Becker’s. “They would have a reach of 150 million prescription users who have taken at least one medication from what they are offering.”

Others aren’t so sure.

Jeff Rosner, executive director of pharmacy sourcing and supply chain analytics of Cleveland Clinic, said it’s “unlikely to be particularly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Provider, Retail care
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin

Share This Article